Literature DB >> 29694446

Clinical, biochemical and genetic risk factors for 30-day and 5-year mortality in 518 adult patients subjected to cardiopulmonary bypass during cardiac surgery - the INFLACOR study.

Maciej Michał Kowalik1, Romuald Lango1, Piotr Siondalski2, Magdalena Chmara3, Maciej Brzeziński2, Krzysztof Lewandowski4, Dariusz Jagielak2, Andrzej Klapkowski2, Jan Rogowski2.   

Abstract

There is increasing evidence that genetic variability influences patients' early morbidity after cardiac surgery performed using cardiopulmonary bypass (CPB). The use of mortality as an outcome measure in cardiac surgical genetic association studies is rare. We publish the 30-day and 5-year survival analyses with focus on pre-, intra-, postoperative variables, biochemical parameters, and genetic variants in the INFLACOR (INFLAmmation in Cardiac OpeRations) cohort. In a prospectively recruited cohort of 518 adult Polish Caucasians, who underwent cardiac surgery in which CPB was used, the clinical data, biochemical parameters, IL-6, soluble ICAM-1, TNFα, soluble E-selectin, and 10 single nucleotide polymorphisms were evaluated for their association with 30-day and 5-year mortality. The 30-day mortality was associated with: pre-operative prothrombin international normalized ratio, intra-operative blood lactate, postoperative serum creatine phosphokinase, and acute kidney injury requiring renal replacement therapy (AKI-RRT) in logistic regression. Factors that determined the 5-year survival included: pre-operative NYHA class, history of peripheral artery disease and severe chronic obstructive pulmonary disease, intra-operative blood transfusion; and postoperative peripheral hypothermia, myocardial infarction, infection, and AKI-RRT in Cox regression. Serum levels of IL-6 and ICAM-1 measured three hours after the operation were associated with 30-day and 5-year mortality, respectively. The ICAM1 rs5498 was associated with 30-day and 5-year survival with borderline significance. Different risk factors determined the early (30-day) and late (5-year) survival after adult cardiac surgery in which cardiopulmonary bypass was used. Future genetic association studies in cardiac surgical patients should account for the identified chronic and perioperative risk factors.

Entities:  

Keywords:  30-day mortality; 5-year mortality; ICAM-1; ICAM1 rs5498; cardiac surgery; cardiopulmonary bypass; renal replacement therapy.

Mesh:

Year:  2018        PMID: 29694446     DOI: 10.18388/abp.2017_2361

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  2 in total

Review 1.  Evaluation of Inflammation Caused by Cardiopulmonary Bypass in a Small Animal Model.

Authors:  Yutaka Fujii
Journal:  Biology (Basel)       Date:  2020-04-20

Review 2.  Narrative review of the systemic inflammatory reaction to cardiac surgery and cardiopulmonary bypass.

Authors:  Enrico Squiccimarro; Alessandra Stasi; Roberto Lorusso; Domenico Paparella
Journal:  Artif Organs       Date:  2022-01-21       Impact factor: 2.663

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.